期 |
标题 |
文件 |
卷 3, 编号 1 (2001) |
Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya |
|
Semiglazov V., Semiglazov V., Ivanov V., Bershteyn L., Tsyrlina E., Zhil'tsova E., Arzumanov A., Nurgaziev K.
|
卷 23, 编号 2 (2021) |
Isatuximab, a novel anti-CD38 monoclonal antibody in the treatment of multiple myeloma: efficacy and safety |
 (Rus)
|
Zatolochina K., Zyryanov S., Ushkalova E.
|
卷 4, 编号 3 (2002) |
Novoe napravlenie v lechenii khronicheskogo bolevogo sindroma u onkologicheskikh bol'nykh |
|
Isakova M., Pavlova Z., Bryuzgin V.
|
卷 6, 编号 2 (2004) |
Novye aktsenty v endokrinnoy terapii raka molochnoy zhelezy |
|
Makarenko N.
|
卷 16, 编号 1 (2014) |
New aspects of the first-line chemotherapy in colorectal cancer |
|
Artamonova E.
|
卷 20, 编号 2 (2018) |
New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors |
 (Rus)
|
Laktionov K., Reutova E., Nelyubina L., Pitkevich M., Okruzhnova M., Ardzinba M., Yudin D., Demidova I., Zaretsky A.
|
卷 3, 编号 2 (2001) |
Novye vozmozhnosti v terapii zrelokletochnykh nekhodzhkinskikh limfom: preparat "Mabtera" - nastoyashchee i budushchee |
|
Poddubnaya I., Osmanov D., Probatova N., Tupitsin N., Kruglova G., Kuril'nikov A., Sholokhova E., Manzyuk L., Borodkina A., Shirin A., Unukova E., Zeynalova P., Byalik T., Sorokin E., Petrov O.
|
卷 22, 编号 2 (2020) |
New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas |
 (Rus)
|
Poddubnaya I., Ptushkin V., Belousova I., Gorenkova L., Kaplanov K., Karamova A., Kovrigina A., Kolomeitsev O., Konstantinova T., Kokhan M., Pospelova T.
|
卷 14, 编号 2 (2012) |
Novye vozmozhnosti targetnoy terapii v onkodermatologii |
|
- -.
|
卷 10, 编号 1 (2008) |
Novye vozmozhnosti targetnoy terapii neyropaticheskoy boli v onkologii |
|
Abuzarova G., Prokhorov B., Sokolenov A., Shakhnovich E.
|
卷 13, 编号 2 (2011) |
Novye vozmozhnosti targetnoy terapiirasprostranennogo raka pochki |
|
- -.
|
卷 26, 编号 3 (2024) |
New therapies for hormone-positive HER2-negative metastatic breast cancer with AKT signaling alterations: the Expert Panel Decision |
 (Rus)
|
Editorial B.
|
卷 27, 编号 2 (2025) |
Novel therapies for the metastatic HER2-positive breast cancer with metastases in the central nervous system: a clinical case |
 (Rus)
|
Radyukova I., Rats N.
|
卷 18, 编号 2 (2016) |
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer |
 (Rus)
|
Semiglazova T., Klyuge V., Semiglazov V., Teletaeva G., Krivorotko P., Dashyan G., Paltuev R., Tkachenko E., Donskikh R., Semiglazov V.
|
卷 15, 编号 2 (2013) |
New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer |
|
Artamonova E., Manzyuk L.
|
卷 3, 编号 3 (2001) |
Novye vozmozhnosti endokrinnoy terapii raka molochnoy zhelezy |
|
Makarenko N., Poddubnaya I.
|
卷 13, 编号 3 (2011) |
Novye vozmozhnostiv lechenii raka pryamoy kishki |
|
Artamonova E.
|
卷 16, 编号 2 (2014) |
New horizons in skin malignancies treatment |
|
Gamaunov S.
|
卷 9, 编号 1 (2007) |
Novye gorizonty immunoterapii nekhodzhkinskikh limfom iz kletok zony mantii |
|
Poddubnaya I.
|
卷 3, 编号 4 (2001) |
Novye immunologicheskie markery (CD71 , LU-BCRU-G7), vzaimosvyazannye s prognozom raka molochnoy zhelezy |
|
Tupitsyn N., Letyagin V., Panichenko A., Vasil'ev M., Shinkarev S., Artamonova E., Ognerubov N., Ermilova V., Ryazantseva S.
|
卷 13, 编号 3 (2011) |
Novye lekarstvennye preparatyv terapii raka predstatel'noyzhelezy, rezistentnogo k kastratsii |
|
Petrov S., Nosov A., Vorob'ev N.
|
卷 13, 编号 4 (2011) |
Novye rekomendatsii EORTC po primeneniyugranulotsitarno-koloniestimuliruyushchegofaktora (G-KSF) dlya snizheniya riskarazvitiya febril'noy neytropenii (FN)u vzroslykh patsientov s limfomamii solidnymi opukholyami.Algoritm opredeleniya riska razvitiya FNi primenenie G-KSF |
|
- -.
|
卷 13, 编号 2 (2011) |
Novye strategii terapii zlokachestvennykhlimfoproliferativnykh zabolevaniyobsuzhdalis' v Sankt-Peterburgena forume onkogematologov |
|
- -.
|
卷 4, 编号 1 (2002) |
Novyy vek - novye vozmozhnosti khimioterapii: temodal v lechenii zlokachestvennykh opukholey |
|
Poddubnaya I.
|
卷 14, 编号 3 (2012) |
Novyy vzglyad na biologicheskie osobennosti pervichnoy ekstranodal'noy diffuznoy V-krupnokletochnoy limfomy |
|
Subortseva I., Kovrigina A., Korobko I., Poddubnaya I.
|
卷 5, 编号 3 (2003) |
Novyy vzglyad na neoad\"yuvantnuyu khimioterapiyu raka molochnoy zhelezy (rol' navel'bina) |
|
Semiglazov V., Arzumanov A., Bozhok A., Paltuev R., Topuzov E., Semiglazov V., Klettsel' A., Nurgaziev K., Ivanova O., Petrovskiy S.
|
卷 10, 编号 4 (2008) |
Novyy shag k prodleniyu zhizni bol'nykh metastaticheskim rakom pecheni |
|
- -.
|
卷 20, 编号 1 (2018) |
Nosological structure of patients in oncohematology department at the Loginov Moscow Clinical Scientific Center for 2016 year |
 (Rus)
|
Pivnik A., Dudina G., Petrenko A., Tumanova M., Stuklov N., Leyghton R., Nikerova L., Dubnitskaya M., Mukhin O., Kremneva N., Fedorova V.
|
卷 25, 编号 3 (2023) |
Nutritional support in oncology: the place of parenteral nutrition (literature review) |
 (Rus)
|
Pasechnik I., Skobelev E., Boldyreva T.
|
卷 24, 编号 1 (2022) |
Nutritional support in the perioperative period of treatment of cancer patients: Retrospective cohort study |
 (Rus)
|
Gameeva E., Stepanovna A., Khoronenko V., Gridnev O., Sviridov S., Shestopalov A.
|
卷 25, 编号 2 (2023) |
Nutritional support for primary patients with esophageal cancer (analytical review) |
 (Rus)
|
Obukhova O., Kurmukov I., Abu-Khaidar O.
|
卷 18, 编号 4 (2016) |
Nutritional status of children with cancer and hematological malignancies during treatment in FSBI Federal Scientific Clinical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev (screening results) |
|
Vasilyeva E., Vashura A., Litvinov D.
|
卷 24, 编号 3 (2022) |
Multidisciplinary interaction of Russian professional communities in oncology |
 (Rus)
|
Khatkov I., Andreyashkina I., Zelenova E., Trotsenko I.
|
卷 12, 编号 3 (2010) |
Obzor konferentsii ekspertovv oblasti lekarstvennoy terapii rakapochki «Novye vozmozhnosti v terapiimetastaticheskogo raka pochki» |
|
Volkova L.
|
卷 17, 编号 4 (2015) |
Review of the Event: The role of local biosimilar drugs and original biological drugs in modern cancer treatment |
|
- -.
|
卷 14, 编号 4 (2012) |
Obrazovatel'nye meropriyatiyav oblasti abdominal'noy onkologii |
|
- -.
|
卷 7, 编号 2 (2005) |
Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga |
|
Karakhan V., Aleshin V., Fu R., Krat V.
|
卷 9, 编号 3 (2007) |
Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy |
|
Khvastunov R., Kireev A., Nikol'skiy I., Suvorov V.
|
卷 24, 编号 4 (2022) |
Oxycodone for cancer-related pain in adults (Russian Translation of Cochrane Plain Language Summary (PLS)) |
 (Rus)
|
Bayazitova R.
|
卷 20, 编号 3 (2018) |
Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients |
 (Rus)
|
Artamonova E., Kovalenko E., Snegovoy A., Aksarin A., Anciferova T., Belonogov A., Bilan E., Bilenko S., Varvus I., Gorkovenko E., Enikeev R., Ermolaeva A., Kramskaya L., Kononenko I., Pechenyy A., Safina S., Chupriyanova T., Chuhua G., Shemyakina A., Shikina E.
|
卷 19, 编号 3 (2017) |
Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer |
 (Rus)
|
Khokhlova S.
|
卷 7, 编号 1 (2005) |
Opioidnyy anal'getik tsentral'nogo deystviya tramadola gidrokhlorid (tramal) pri lechenii khronicheskoy boli u onkologicheskikh bol'nykh |
|
Isakova M., Pavlova Z., Bryuzgin V.
|
卷 14, 编号 1 (2012) |
Opisanie klinicheskikhsluchaev primeneniya kombinatsiys lapatinibom v lecheniiHER2-pozitivnogo rasprostranennogoraka molochnoy zhelezy |
|
Bolotina L., Kramskaya L., Smirnova I., Zharikova I., Aminov G.
|
卷 13, 编号 1 (2011) |
Opredelenie HER2/neu-statusa po gistologicheskomu materialu -est' li prostranstvo dlya diskussii? |
|
Borbat A., Tkachenko E., Pozharisskiy K.
|
卷 26, 编号 1 (2024) |
Detection of mutations in the BRAF in patients with melanoma in routine clinical practice: Survey results |
 (Rus)
|
Orlova K., Demidov L.
|
卷 23, 编号 2 (2021) |
The identification of tumor-infiltrating lymphocytes in patients with stomach cancer |
 (Rus)
|
Khakimova G., Bozhchenko Y., Zabotina T., Tryakin A.
|
卷 25, 编号 1 (2023) |
Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical Sentiscan. A case series |
 (Rus)
|
Shevchuk A., Krylov A., Knyazev R., Afanasieva K.
|
卷 20, 编号 2 (2018) |
Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved? |
 (Rus)
|
Zhukova L., Ganshina I., Khatkova E., Tikhomirova T., Kondratyeva O.
|
卷 18, 编号 1 (2016) |
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options |
 (Rus)
|
Artamonova E., Manzyuk L.
|
卷 6, 编号 2 (2004) |
Optimizatsiya kombinirovannogo lecheniya bol'nykh mestno-rasprostranennym rakom gortanoglotki |
|
Madzhidov M.
|
卷 12, 编号 4 (2010) |
Optimizatsiya metodov lecheniyakhronicheskogo bolevogo sindroma u bol'nykhs metastazami v kosti disseminirovannogoraka molochnoy zhelezy |
|
Kogoniya, L., Mos'kin V.
|
卷 22, 编号 4 (2020) |
Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor |
 (Rus)
|
Ganshina I., Ivanova K., Lubennikova E., Arkhipov A., Zhukova L.
|
卷 14, 编号 1 (2012) |
Opukhol' Abrikosova:porazhenie legkikh u rebenka 4 let |
|
Seroklinov V., Kozhevnikov V., Chursin A., Bylina E., Logvinova T., Drachev V., Starodubtsev E., Mizernitskiy Y.
|
卷 12, 编号 1 (2010) |
Opyt GNTs RAMN po primeneniyunilotiniba (Tasigna) u bol'nykhv khronicheskoy faze khronicheskogomieloleykoza pri neudache terapiiimatinibom |
|
Gusarova G., Turkina A., Domracheva E., Tikhonova L., Egorova M., Kolosheynova T., Stakhina O., Nemchenko I., Vakhrusheva M., Chelysheva E., Zakharova E., Goryacheva S., Sokolova M., Kuznetsov S., Afanas'eva N., Khoroshko N.
|
卷 13, 编号 1 (2011) |
Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya |
|
Zhukova L., Okruzhnova M., Lubennikova E., Zeynalova K.
|
卷 26, 编号 4 (2024) |
Experience of Next-Generation Sequencing in urothelial carcinoma specimens with panel for 523 genes |
 (Rus)
|
Gridneva Y., Khmelkova D., Volkova M., Blagodatskikh K., Zheludkevich A., Semenova A., Veshchevailov A., Babkina A., Bondarev S., Galkin V.
|
卷 16, 编号 3 (2014) |
Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer |
|
Gridneva Y., Matveev V., Kupchan D., Kalinin S., Peters M.
|
卷 12, 编号 1 (2010) |
Opyt lecheniya kapetsitabinomi trastuzumabom metastaticheskogoporazheniya golovnogo mozga pri rakemolochnoy zhelezy s giperekspressieyHer-2/neu |
|
Naskhletashvili D., Chmutin G., Karakhan V., Aleshin V., Fu R., Moskvina E., Belov D., Luk'yanchenko A., Ivanova E.
|
卷 15, 编号 2 (2013) |
Experience with Hyposalix spray treatment for xerostomia |
|
Afanasyev V., Titova O., Ordashev K., Ugurchiev Y.
|
卷 24, 编号 2 (2022) |
Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report |
 (Rus)
|
Gushchina E., Vernyuk M., Chervontseva A., Cherkashina I., Khayrullina L., Lunin V., Fedenko A.
|
卷 24, 编号 3 (2022) |
Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report |
 (Rus)
|
Semenov E., Gasymly D., Zyuzyukina A., Zukov R.
|
卷 12, 编号 1 (2010) |
Opyt lecheniya stromal'nykh opukholeyzheludochno-kishechnogo traktav Chelyabinskoy oblasti |
|
Antonov A., Nadvikova E., Vazhenin A.
|
卷 16, 编号 4 (2014) |
Radiation treatment of the primary vulvar Pagetʼs disease: case report |
|
Razumova E., Kizhaev Y., Ukolova E.
|
卷 25, 编号 3 (2023) |
Experience in organizing nutritional support in cancer patients at the Tsyb Medical Radiological Research Centre |
 (Rus)
|
Potapov A., Аgababyan T., Dorozhkin A., Pimonova I., Nevolskikh A., Ivanov S., Kaprin A.
|
卷 5, 编号 1 (2003) |
Opyt primeneniya abitaksela™ v lechenii solidnykh opukholey |
|
Blyumenberg A., Gutorov S., Topchieva S., Gorbunova V., Lichinitser M.
|
卷 12, 编号 3 (2010) |
Opyt primeneniya Avastina (bevatsizumaba)v sochetanii s khimioterapiey v lecheniirasprostranennykh form nemelkokletochnogoraka legkogo v otdelenii torakal'noyonkologii |
|
Orlov S., Stel'makh L., Lozhkina A., Poltoratskiy A.
|
卷 14, 编号 3 (2012) |
Opyt primeneniya bendamustina u patsientov s retsidivom khronicheskogo limfoleykoza v rezhime monoterapii v ambulatornykh usloviyakh |
|
Ivashchenko A.
|
卷 15, 编号 3 (2013) |
Opyt primeneniya Votrienta v kombinirovannom lechenii redkikh mestno-rasprostranennykh sarkom myagkikh tkaney vysokoy stepeni zlokachestvennosti |
|
Zubarev A., Kuril'chik A., Starodubtsev A., Ivanov V.
|
卷 8, 编号 1 (2006) |
Opyt primeneniya vysokodoznoy khimioterapii pri retsidiviruyushchem techenii i refrakternykh formakh limfomy Khodzhkina (retrospektivnyy analiz dannykh chetyrekh transplantatsionnykh tsentrov Respubliki Belarus', Rossiyskoy Federatsii i Ukrainy) |
|
Zhukov N., Uss A., Afanas'ev B., Karamanesht E., Ptushkin V.
|
卷 13, 编号 1 (2011) |
Opyt primeneniya gefitiniba v lechenii nemelkokletochnogo raka legkikh v Orlovskoy oblasti |
|
Golubenko R., Gromov G., Vishnevskiy V.
|
卷 14, 编号 4 (2012) |
Opyt primeneniya kapetsitabina v neoad\"yuvantnoy khimioterapii raka molochnoy zhelezy |
|
Slonimskaya E., Tarabanovskaya N., Bragina O., Garbukov E., Doroshenko A., Kokorina Y., Zav'yalova M.
|
卷 11, 编号 1 (2009) |
Opyt primeneniya kapetsitabinau bol'nykh rakom molochnoy zhelezy s metastazami v golovnoy mozg |
|
Naskhletashvili D., Chmutin G., Karakhan V., Aleshin V., Fu R., Belov D., Ivanova E.
|
卷 25, 编号 3 (2023) |
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis |
 (Rus)
|
Lyadova M., Fedorinov D., Kuzmina E., Antonova T., Sokolskaya V.
|
卷 17, 编号 3 (2015) |
Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors |
|
Markovich A., Kuzminov A., Orel N., Odintsova A., Emelyanova G., Gorbunova V.
|
卷 19, 编号 2 (2017) |
Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0 |
 (Rus)
|
Manikhas A., Grinev I., Oganesian A., Chikrizov S., Manikhas G.
|
卷 19, 编号 2 (2017) |
Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer |
 (Rus)
|
Kit O., Vladimirova L., Abramova N., Storozhakova A., Popova I., Tikhanovskaya N., Lyaynova A., Ryadinskaya L.
|
卷 24, 编号 2 (2022) |
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study |
 (Rus)
|
Sultanbaev A., Menshikov K., Musin S., Nasretdinov A., Fatikhova A., Izmailov A., Lipatov O., Ayupov R., Sultanbaeva N., Menshikova I., Serebrennikov G.
|
卷 9, 编号 2 (2007) |
Opyt primeneniya preparata Vero-kladribin u bol'nykh volosatokletochnym leykozom |
|
Al'-Radi L., Moiseeva T., Kravchenko S.
|
卷 25, 编号 3 (2023) |
Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study |
 (Rus)
|
Evdokimov V., Bloshchinenko A., Abolmasov A., Vilensky A., Laskov M.
|
卷 10, 编号 2 (2008) |
Opyt primeneniya preparata Eloksatin pri kolorektal'nom rake |
|
Voznyy E., Popov A., Astrakhankina T., Grishunenkova E., Polyanskaya E.
|
卷 26, 编号 1 (2024) |
Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study |
 (Rus)
|
Levashov A., Zagidullina S., Valiev T., Stroganova A., Khochenkov D., Grigorenko V., Mikhaylova E., Tyurina E., Ryzhova M., Horielyshev S., Kadirov S., Polyakov V.
|
卷 7, 编号 1 (2005) |
Opyt primeneniya Regional'noy programmy v g. Krasnodare |
|
Mitashok I.
|
卷 19, 编号 3 (2017) |
The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation |
 (Rus)
|
Kolomeytseva A., Yemelyanova G., Gorbunova V., Orel N., Perevodchikova N., Bokhyan V., Fedenko A.
|
卷 4, 编号 3 (2002) |
Opyt primeneniya taksola v khimioterapii ploskokletochnogo raka golovy i shei |
|
Podvyaznikov S., Byakhov M.
|
卷 8, 编号 1 (2006) |
Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy |
|
Samoylenko V., Gorbunova V., Koshelev M., Yurashko K.
|
卷 16, 编号 3 (2014) |
Experience of eribulin application in previously treated patients with metastatic or locally recurrent breast cancer under the clinical trial |
|
Ahmetzanov F., Ahmetzanova F.
|
卷 14, 编号 4 (2012) |
Opyt provedeniya nablyudatel'nykhprogramm v abdominal'noy onkologii |
|
- -.
|
卷 18, 编号 3 (2016) |
Experience in prevention of neutropenia in patients with disseminated soft tissue sarcomas receiving polychemotherapy |
 (Rus)
|
Vladimirova L., Mitashok I., Snezhko T., Samaneva N., Storozhakova A., Kornilova I.
|
卷 8, 编号 2 (2006) |
Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh |
|
Barkagan Z., Khodorenko S., Mamaev A., Nazarov A., Mamaeva I., Tsyvkina L., Rossokha A.
|
卷 23, 编号 2 (2021) |
Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period |
 (Rus)
|
Bukharov A., Derzhavin V., Yadrina A., Erin D.
|
卷 3, 编号 2 (2001) |
Opyt trakheobronkhoplasticheskikh operatsiy pri opukholyakh legkikh i trakhei |
|
Novikov E., Aminodov S., Solov'ev V., Smirnov A.
|
卷 14, 编号 2 (2012) |
Opyt uspeshnogo lecheniya HER2-pozitivnogo metastaticheskogo raka zheludka |
|
Gamayunov S., Slugarev V., Ter-Ovanesov M., Zakharova E.
|
卷 25, 编号 2 (2023) |
Experience of surgical treatment of hemangioma of the spleen. A clinical case |
 (Rus)
|
Chekini A., Novikov D., Avturkhanov T., Mkrtumyan R., Novikova A.
|
卷 5, 编号 3 (2003) |
Oral'nyy vepezid v lechenii retsidivov i platinorezistentnykh form raka yaichnikov (opyt primeneniya) |
|
Makhnova E.
|
卷 5, 编号 1 (2003) |
Organizatsionno-metodicheskie aspekty realizatsii Regional'noy programmy lecheniya mestno-rasprostranennogo i metastaticheskogo raka molochno y zhelezy s ispol'zovaniem rezhima dotsetaksel/doksorubitsin |
|
Podregul'skiy K., Poddubnaya I.
|
卷 3, 编号 1 (2001) |
Organosokhranyayushchee lechenie - perspektivnoe napravlenie razvitiya onkopediatrii XXI veka |
|
Durnov L., Sharoev T., Polyakov V., Ivanova N., Lebedev V., Pashkov Y., Bondar' I., Belkina B., Boychenko E.
|
卷 12, 编号 1 (2010) |
Original'naya kombinatsiyaFtorafur® + vinorelbinv lechenii raka molochnoy zhelezy:pervye rezul'taty |
|
Manzyuk L., Artamonova E., Satirova E., Alatortseva E.
|
卷 8, 编号 3 (2006) |
Ortopedicheskaya reabilitatsiya onkologicheskikh bol'nykh s defektami verkhney chelyusti |
|
Chuykov M., Matyakin E., Azizyan R., Akhundov A., Mudunov A., Podvyaznikov O., Fedotov N., Chuchkov M., Agapov V.
|
卷 21, 编号 3 (2019) |
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer |
|
Reutova E., Laktionov K., Iudin D., Neliubina L., Gorokhova G., Egorova A.
|
卷 24, 编号 1 (2022) |
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report |
 (Rus)
|
Orlov S., Baldin P., Diuzeva N., Krechetova A., Mordovskiy A., Moskovchenko A., Musaeva N., Romanchuk O.
|
卷 7, 编号 2 (2005) |
Osnovnye aspekty primeneniya bisfosfonatov v onkologii |
|
Kondrat'eva A.
|
卷 15, 编号 4 (2013) |
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature) |
|
Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.
|
卷 5, 编号 2 (2003) |
Osnovnye napravleniya sovremennoy luchevoy terapii zlokachestvennykh opukholey |
|
Kondrat'eva A.
|
卷 5, 编号 4 (2003) |
Osnovnye problemy optimizatsii okazaniya onkologicheskoy pomoshchi naseleniyu( Yakutsk, 1992 - 2002 gg.) |
|
Poddubnaya I., Aksel' E., Ivanov P., Ivanova R., Kipriyanova N., Afanas'eva L.
|
卷 22, 编号 3 (2020) |
Features of management of oncohematological patients in the context of the COVID-19 pandemic |
 (Rus)
|
Poddubnaya I., Tumian G., Trofimova O., Babicheva L., Bariakh E., Poliakov A.
|
卷 22, 编号 2 (2020) |
Cancer patient management during the COVID-19 pandemic Training module. Version 2 from 30.04.2020 |
 (Rus)
|
Poddubnaya I., Sychev D., Abuzarova G., Allakhverdiev A., Arkhiri P., Babicheva L., Baranova M., Volkova M., Ignatova A., Kashurnikov A., Kniazev R., Kolyadina I., Komarov I., Kriukov A., Levitskaia N., Liadov V., Malikhova O., Nered S., Orel N., Podviaznikov S., Sagaidak I., Sarmanaeva R., Stilidi I., Trofimova O., Tumian G., Kharitonova T.
|
卷 19, 编号 4 (2017) |
Principles of diagnosis and surgical treatment of patients with retroperitoneal schwannomas |
 (Rus)
|
Bugaev V., Nikulin M., Melikov S.
|
卷 8, 编号 3 (2006) |
Osobennosti kliniko-morfologicheskikh kharakteristik i lecheniya retsidiva raka yaichnikov IV stadii |
|
Mel'ko A., Ushakov I., Kira E., Shamkina V., Gaytukieva R.
|
卷 8, 编号 4 (2006) |
Osobennosti klinicheskogo techeniya i prognoz bol'nykh nekhodzhkinskoy limfomoy s pervichnoy lokalizatsiey v yaichke |
|
Tumyan G., Kovrigina A., Timofeeva O., Probatova N., Sholokhova E., Tupitsyn N., Poddubnaya I., Osmanov D.
|
卷 17, 编号 3 (2015) |
Osobennosti korrektsii naibolee chastykh nezhelatel'nykh yavleniy na fone primeneniya ingibitorov BRAF i MEK |
|
Samoylenko I.
|
卷 4, 编号 4 (2002) |
Osobennosti lecheniya bol'noy neorgannoy pleomorfnoy liposarkomoy |
|
Blyumenberg A., Kuznetsov V., Gorbunova V., Mikhina Z., Borisov V., Gubin A., Poddubnyy B., Petrovichev N., Kiselevskiy M., Zakharova T., Kireev A., Vakurova E., Rotin D.
|
卷 18, 编号 5 (2016) |
Characteristics of approach to the treatment of chronic pain in terminal cancer patients |
|
Nevzorova D., Ibragimov A., Bakunina E.
|
卷 19, 编号 1 (2017) |
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer |
 (Rus)
|
Demidova I.
|
卷 23, 编号 4 (2021) |
Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III |
 (Rus)
|
Morozov D., Kolyadina I., Poddubnaya I., Ganshina I., Khokhlova S., Kоmetova V., Rodionov V.
|
卷 9, 编号 3 (2007) |
Osobennosti profilaktiki posleoperatsionnykh tromboembolicheskikh oslozhneniy u patsientov so zlokachestvennymi zabolevaniyami |
|
Pashanov E., Zamyatin M., Stoyko Y., Rumyantsev A.
|
卷 17, 编号 3 (2015) |
Osobennosti profilya toksichnosti ingibitorov BRAF i MEK |
|
Protsenko S.
|
卷 16, 编号 4 (2014) |
Features of development of metachronous and synchronous tumors in the population of Belgorod region associated with the consequences of the Chernobyl accident |
|
Kovalenko B., Golivets T., Podvyaznikov S.
|
卷 10, 编号 3 (2008) |
Osobennosti reproduktivnoy funktsii u zhenshchin s onkogematologicheskimi zabolevaniyami |
|
Shmakov R., Polushkina E.
|
卷 5, 编号 2 (2003) |
Osobennosti serdechno-dykhatel'nogo sinkhronizma u zhenshchin s razlichnym tonusom vegetativnoy nervnoy sistemy na etape postanovki onkologicheskogo diagnoza |
|
Arkad'eva T., Selyan N.
|
卷 18, 编号 1 (2016) |
Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy |
 (Rus)
|
Kolyadina I., Poddubnaya I., Pavlikova O., Komov D.
|
卷 13, 编号 3 (2011) |
Osteopontin, CD55:prognosticheskie faktory riskapri rake molochnoy zhelezy |
|
Guzieva Z., Poddubnaya I., Vishnevskaya Y., Makarenko N., Sytenkova K.
|
卷 24, 编号 1 (2022) |
From the editor-in-chief of the journal "Modern Oncology" Academician of the Russian Academy of Sciences I.V. Poddubnaya |
 (Rus)
|
Poddubnaya I.
|
卷 10, 编号 3 (2008) |
Ot glavnogo redaktora Uvazhaemye kollegi! |
|
Poddubnaya I.
|
卷 18, 编号 1 (2016) |
Long-term effects of pediatric cancer therapy: 35-year clinical experience |
 (Rus)
|
Zaeva G., Valiev T., Gavrilenko T., Moiseenko E., Medvedovskaya E., Mikhailova S., Sinyagina Y.
|
卷 11, 编号 3 (2009) |
Otdalennye rezul'taty khirurgicheskogo lecheniya gastrointestinal'nykh stromal'nykh opukholey zheludochno-kishechnogo trakta |
|
Istomin Y., Evdokimov M.
|
卷 7, 编号 3 (2005) |
Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy |
|
Konstantinova M., Gershanovich M., Akimov M., Nosov D., Bogdanova N.
|
卷 3, 编号 1 (2001) |
Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov) |
|
Poddubnaya I., Khasanov R., Ruchkin V., Lazarev A., Byakhov M., Vtoraya O., Yurchenko V.
|
卷 27, 编号 1 (2025) |
Long-term aesthetic outcomes of reconstructive surgeries with endoprosthetics for breast cancer: A review |
 (Rus)
|
Khomidi U., Vlasova M., Saribekyan E., Zikiryakhodzhaev A., Khakimova S., Khakimova G., Kodzoeva D.
|
卷 18, 编号 2 (2016) |
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study |
 (Rus)
|
Ignatova E., Burdaeva O., Kopp M., Kotiv B., Udovitsa D., Stroiakovskii D., Alekseev S., Sheveleva L., Khorinko A., Shapovalova I., Moiseenko V., Ivanov R.
|
卷 19, 编号 3 (2017) |
Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer |
 (Rus)
|
Nenakhova Y., Lyadov V., Poddubnaya I.
|
卷 23, 编号 1 (2021) |
Assessment and correction of the geriatric status of patients with metastatic colorectal cancer during the first-line systemic therapy |
 (Rus)
|
Alekseeva Y., Semiglazova T., Sharashenidze S., Tkachenko E., Kasparov B., Brish N., Teletaeva G., Filatova L., Sluzhev M., Semiglazov V., Protsenko S., Belyaev A.
|
卷 25, 编号 3 (2023) |
Clinical and economic benefits of parenteral iron carboxymaltosate in patients with gynecological cancers: A retrospective observational study |
 (Rus)
|
Saevets V., Shamanova A.
|
卷 26, 编号 2 (2024) |
Clinical benefits of parenteral iron carboxymaltose in patients with colorectal cancer: a retrospective observational study |
 (Rus)
|
Postolov M., Suvorov V., Kravets A.
|
卷 24, 编号 4 (2022) |
Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region |
 (Rus)
|
Zhuikova L., Ananina O., Sirotina A., Pikalova L., Fokin V., Kononova G.
|
卷 25, 编号 4 (2023) |
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] |
 (Rus)
|
Yudina E.
|
卷 3, 编号 4 (2001) |
Otsenka toksichnosti protivoopukholevogo preparata gemtsitabina (GEM) |
|
Mamedov F., Narimanov M., Bazin I., Efimov O., Zharkov S., Tryakin A., Tyulyandin S., Garin A.
|
卷 14, 编号 2 (2012) |
Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progressiya opukholevogo protsessa posle khimioterapii taksanami |
|
Gafanov R., Ivanov S., Fastovets S., Isaev T.
|
卷 26, 编号 3 (2024) |
Evaluation of the effectiveness of hematopoietic blood stem cell mobilization using empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases: the experience of several centers in the Russian Federation. A retrospective study |
 (Rus)
|
Nesterova E., Mangasarova J., Bagova M., Fastova E., Magomedova A., Margolin O., Gorenkova L., Abdurashidova R., Galtseva I., Nakastoev I., Galuzyak V., Baiteryakova O., Shcherbakova A., Telyashov M., Spitsyn V., Sukhorukov D., Gemdzhian E., Zvonkov E., Petrova G., Sarzhevskiy V., Shorokhov N., Voloshin S., Linnikov S., Drozd M., Simashova P., Pop V., Rukavitsyn O., Davydova N., Arushanyan M.
|
卷 11, 编号 3 (2009) |
Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy |
|
Konstantinova M., Savkova R., Demidov L., Gorbunova V., Kharkevich G., Antimonik N., Merkulov V., Simanovich E., Ral'chenko K., Sbrodov O.
|
卷 14, 编号 3 (2012) |
Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay) |
|
Savkov R.
|
卷 3, 编号 4 (2001) |
Paklitaksel (taksol): novye vozmozhnosti. Ezhenedel'nyy rezhim vvedeniya |
|
Voznyy E.
|
卷 17, 编号 3 (2015) |
Pamyati Gianni Bonadonna |
|
- -.
|
卷 12, 编号 3 (2010) |
Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti |
|
Artamonova E.
|
卷 4, 编号 4 (2002) |
Parametry serdechno-dykhatel'nogo sinkhronizma i prognoz razvitiya onkologicheskogo zabolevaniya |
|
Arkad'eva T., Ostrizhnaya N.
|
卷 15, 编号 1 (2013) |
Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients |
|
Romanenko N.
|
卷 25, 编号 4 (2023) |
Patient resource to improve the effectiveness of oncological care for the population |
 (Rus)
|
Kozlov V., Samsonov I., Mushnikov D.
|
卷 8, 编号 2 (2006) |
Pemetreksed (alimta) |
|
Tyulyandin S.
|
卷 22, 编号 2 (2020) |
First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice |
 (Rus)
|
Babicheva L., Poddubnaya I.
|
卷 10, 编号 3 (2008) |
Pervichnaya mediastinal'nayaV-krupnokletochnaya limfoma: diagnostika, klinicheskaya kartina i lechenie |
|
Tumyan G., Kovrigina A., Kichigina M., Sorokin E., Bykov D., Kondrat'eva T., Probatova N., Trofimova O., Kolomeytsev O., Poddubnaya I., Tupitsyn N., Larionova V., Osmanov D.
|
卷 25, 编号 3 (2023) |
Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] |
 (Rus)
|
Melnikov V.
|
601 - 750 的 1398 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |